A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review
- 2 March 2012
- journal article
- review article
- Published by Springer Nature in Gastric Cancer
- Vol. 15 (S1) , 164-167
Abstract
Complete resection of a gastric cancer and adjacent lymph nodes offers the only chance for cure of the disease. However, disease recurrence occurs in 22–51% of cases, and its prognosis is very poor. Many clinicians perform post-operative follow-up for these patients, although there is no consensus on the regimen, frequency of visits, mode of testing, or the rationale of a follow-up program. The objective of this systematic review was to identify the evidence for surveillance in patients with resected gastric cancer, specifically examining the interval of follow-up and the modalities utilized. Electronic literature searches were conducted using Medline, Embase, and the Cochrane Central Register of Controlled Trials from January 1st 1998 to December 1st 2009. All search titles and abstracts were independently rated for relevance by a minimum of two reviewers. Five articles were selected. A total of 810 patients underwent post-operative follow-up. History and physical examination, hematological and chemistry profile, endoscopy (esophagogastroduodenoscopy [EGD]), and computed tomography (CT) were the most frequently employed modalities. CT detected the majority of recurrences in the included studies. The survival post-recurrence was significantly higher in the asymptomatic group compared with symptomatic group in three studies, but this may simply reflect lead-time bias. No differences in overall survival (OS) were found. The included studies failed to show an improvement in OS with more intense surveillance. Further prospective studies are required to determine whether a subgroup of patients may benefit from more intensive follow-up.Keywords
This publication has 13 references indexed in Scilit:
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- Surveillance Program for Recurrence after Curative Gastric Cancer SurgeryVisceral Medicine, 2007
- Value of intensive follow‐up of patients after curative surgery for gastric carcinomaJournal of Surgical Oncology, 2007
- General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trialBritish Journal of Cancer, 2006
- Is Detection of Asymptomatic Recurrence after Curative Resection Associated with Improved Survival in Patients with Gastric Cancer?Journal of the American College of Surgeons, 2005
- Prediction of Recurrence After Radical Surgery for Gastric CancerAnnals of Surgery, 2005
- Follow-Up Surveillance for Recurrence After Curative Gastric Cancer Surgery Lacks Survival BenefitAnnals of Surgical Oncology, 2003
- Guidelines for the management of oesophageal and gastric cancer.2002
- Guidelines for the management of oesophageal and gastric cancerGut, 2002